Max Masucci
Stock Analyst at TD Cowen
(0.30)
# 3,191
Out of 4,479 analysts
26
Total ratings
17.39%
Success rate
-36.04%
Average return
Main Sectors:
16 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BLFS BioLife Solutions | Maintains: Outperform | $29 → $25 | $20.23 | +23.58% | 1 | Aug 9, 2023 | |
GH Guardant Health | Maintains: Outperform | $70 → $53 | $28.87 | +83.58% | 1 | Feb 24, 2023 | |
HOLX Hologic | Maintains: Outperform | $86 → $95 | $73.53 | +29.20% | 2 | Feb 2, 2023 | |
QTRX Quanterix | Downgrades: Market Perform | $38 → $18 | $12.72 | +41.51% | 2 | Aug 9, 2022 | |
BDSX Biodesix | Initiates: Outperform | n/a | $1.58 | - | 2 | Apr 20, 2022 | |
EVO Evotec SE | Initiates: Outperform | n/a | $4.95 | - | 1 | Nov 29, 2021 | |
NAUT Nautilus Biotechnology | Initiates: Outperform | n/a | $2.27 | - | 1 | Nov 2, 2021 | |
MXCT MaxCyte | Initiates: Outperform | n/a | $3.72 | - | 1 | Aug 24, 2021 | |
CTKB Cytek Biosciences | Initiates: Outperform | n/a | $5.60 | - | 1 | Aug 17, 2021 | |
RPID Rapid Micro Biosystems | Initiates: Outperform | n/a | $0.64 | - | 1 | Aug 9, 2021 | |
TKNO Alpha Teknova | Initiates: Outperform | n/a | $1.23 | - | 1 | Jul 20, 2021 | |
AKYA Akoya Biosciences | Initiates: Buy | n/a | $2.18 | - | 1 | May 11, 2021 | |
ILMN Illumina | Maintains: Buy | n/a | $105.51 | - | 3 | Apr 28, 2021 | |
XGN Exagen | Initiates: Buy | n/a | $1.78 | - | 1 | Apr 15, 2021 | |
TTOO T2 Biosystems | Maintains: Buy | $20,000 → $17,500 | $5.08 | +344,388.19% | 5 | Nov 5, 2020 | |
EXAS Exact Sciences | Maintains: Buy | n/a | $43.17 | - | 2 | Oct 28, 2020 |
BioLife Solutions
Aug 9, 2023
Maintains: Outperform
Price Target: $29 → $25
Current: $20.23
Upside: +23.58%
Guardant Health
Feb 24, 2023
Maintains: Outperform
Price Target: $70 → $53
Current: $28.87
Upside: +83.58%
Hologic
Feb 2, 2023
Maintains: Outperform
Price Target: $86 → $95
Current: $73.53
Upside: +29.20%
Quanterix
Aug 9, 2022
Downgrades: Market Perform
Price Target: $38 → $18
Current: $12.72
Upside: +41.51%
Biodesix
Apr 20, 2022
Initiates: Outperform
Price Target: n/a
Current: $1.58
Upside: -
Evotec SE
Nov 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.95
Upside: -
Nautilus Biotechnology
Nov 2, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.27
Upside: -
MaxCyte
Aug 24, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.72
Upside: -
Cytek Biosciences
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.60
Upside: -
Rapid Micro Biosystems
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.64
Upside: -
Alpha Teknova
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.23
Upside: -
Akoya Biosciences
May 11, 2021
Initiates: Buy
Price Target: n/a
Current: $2.18
Upside: -
Illumina
Apr 28, 2021
Maintains: Buy
Price Target: n/a
Current: $105.51
Upside: -
Exagen
Apr 15, 2021
Initiates: Buy
Price Target: n/a
Current: $1.78
Upside: -
T2 Biosystems
Nov 5, 2020
Maintains: Buy
Price Target: $20,000 → $17,500
Current: $5.08
Upside: +344,388.19%
Exact Sciences
Oct 28, 2020
Maintains: Buy
Price Target: n/a
Current: $43.17
Upside: -